BIAF

bioAffinity Technologies, Inc.

Price

$9.43

return (12m)

-87.38%

p/e

-3.11

p/bv

14.13

DIVIDEND YIELD

0.00%

BIAF price

bioAffinity Technologies, Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BIAF

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

59.16%

3 months

-22.39%

1 year

-87.38%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BIAF

Valuation

P/E

-3.11

Sector 7.84

Industry 7.84

P/BV

14.13

Sector 1.84

Industry 1.84

P/Revenue (PSR)

9.26

Sector 1.78

Industry 1.78

EV/EBITDA

Sector -57.74

Industry -57.74

EV/EBIT

Sector -289.61

Industry -289.61

P/EBITDA

-3.13

Sector -9.38

Industry -9.38

P/EBIT

-3.05

Sector -9.71

Industry -9.71

P/Total Assets

6.99

Sector 0.86

Industry 0.86

P/Net Current Assets

3,599.18

Sector -2.04

Industry -2.04

P/Working Capital

44.97

Sector -4,847.72

Industry -4,847.72

EPS

-3.27

Sector 0.73

Industry 0.73

BVPS

0.72

Sector 9.89

Industry 9.89

Efficiency

Gross Margin

18.93%

Sector 35.14%

Industry 35.14%

EBITDA Margin

-220.77%

Sector 7.88%

Industry 7.88%

EBIT Margin

-224.84%

Sector -7.02%

Industry -7.02%

Operating Margin

-100.00%

Sector 4.32%

Industry 4.32%

Net Profit Margins

-100.00%

Sector 2.76%

Industry 2.76%

Asset Turnover

0.20

Sector 0.11

Industry 0.11

Profitability

ROE

-453.70%

Sector 2.49%

Industry 2.49%

ROA

-224.42%

Sector -0.64%

Industry -0.64%

ROIC

Sector -117.48%

Industry -117.48%

Dividends

Dividend yield

0.00%

Sector 0.50%

Industry 0.50%

Payout

Sector 9.69%

Industry 9.69%

Debt

Current Ratio

1.44

Sector 1.46

Industry 1.46

Net Debt / EBITDA

Sector -20.28

Industry -20.28

Net Debt / EBIT

Sector -165,634,871.06

Industry -165,634,871.06

Net Debt / Equity

Sector -0.77

Industry -0.77

Gross Debt / Equity

Sector 0.06

Industry 0.06

Equity/Assets

0.49

Sector 0.43

Industry 0.43

Liabilities/Assets

0.51

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

22.00%

Sector -

Industry -

Fundamentals BIAF

DRAG THE FRAME TO SEE MORE DATA

BIAF Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.

Average Investor10 user rating

4.0 (1 people)

United States

- year

Founded:

2022

Time since IPO - 4 years

57

Employees

bioAffinity Technologies, Inc. (United States) is listed on the Nasdaq and has a market capitalization of $53.26 million, with shareholders equity totaling $3.77 million.

The company employs approximately 57 people and operates in the Others sector, within the Others industry.

Over the past 12 months, bioAffinity Technologies, Inc. reported $5.75 million in revenue, generating net income of $-17.10 million.

Key financial metrics include a P/E ratio of -3.11, a price-to-book (P/B) ratio of 14.13, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BIAF.

Market cap

$53.26 million

Net worth

$3.77 million

$3,768,797.00

Assets

$7.62 million

$7,619,279.00

Total Shares Outstanding

5.23 million

5,226,000

Average Daily Trading Volume

$401.84 Thousand

$401,836.00

Sector

Others

Industry

Others

BIAF

BIAF revenue and profits

Financial Results BIAF

DRAG THE FRAME TO SEE MORE DATA

BIAF cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$376.90 15,64% (12M)

P/E

22.48

2.41%

ROE

14.27%

P/BV

3.21

SHEL - Shell PLC ADR

$94.54 39,90% (12M)

P/E

10.11

3.98%

ROE

14.29%

P/BV

1.44

STLA - Stellantis NV

$4.82 --51,21% (12M)

P/E

-0.55

0.00%

ROE

-35.93%

P/BV

0.20

COR - Cencora Inc.

$308.78 7,28% (12M)

P/E

22.65

0.78%

ROE

81.08%

P/BV

18.36

ALIZY - Allianz SE ADR

$50.71 --9,19% (12M)

P/E

13.94

2.69%

ROE

17.89%

P/BV

2.49

TTE - TotalEnergies SE ADR

$90.81 62,23% (12M)

P/E

7.30

4.46%

ROE

21.42%

P/BV

1.56

NSRGY - Nestle SA ADR

$92.85 5,99% (12M)

P/E

11.12

4.33%

ROE

58.05%

P/BV

6.46

ELV - Elevance Health Inc

$410.95 34,33% (12M)

P/E

20.04

1.69%

ROE

9.84%

P/BV

1.97